Trevi Therapeutics (TRVI) Short Interest Ratio & Short Volume $4.09 +0.04 (+0.99%) (As of 11:46 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Trevi Therapeutics Short Interest DataTrevi Therapeutics (TRVI) has a short interest of 1.41 million shares. This marks a -19.43% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 616,455 shares to cover all short positions.Current Short Interest1,410,000 sharesPrevious Short Interest1,750,000 sharesChange Vs. Previous Month-19.43%Dollar Volume Sold Short$4.06 millionShort Interest Ratio2.8 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares76,866,000 sharesPercentage of Shares Shorted1.83%Today's Trading Volume309,883 sharesAverage Trading Volume616,455 sharesToday's Volume Vs. Average50% Short Selling Trevi Therapeutics? Sign up to receive the latest short interest report for Trevi Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTRVI Short Interest Over TimeTRVI Days to Cover Over TimeTRVI Percentage of Float Shorted Over Time Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Trevi Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20241,410,000 shares $4.06 million -19.4%N/A2.8 $2.88 11/15/20241,750,000 shares $4.81 million +1.7%N/A3.7 $2.75 10/31/20241,720,000 shares $5.07 million +13.2%N/A4.4 $2.95 10/15/20241,520,000 shares $4.83 million +0.7%N/A4.6 $3.18 9/30/20241,510,000 shares $5.04 million +8.6%N/A5.7 $3.34 9/15/20241,390,000 shares $4.68 million -10.3%N/A5.4 $3.37 Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/20241,550,000 shares $4.90 million +3.3%N/A6.8 $3.16 8/15/20241,500,000 shares $4.13 million +16.3%N/A6.6 $2.75 7/31/20241,290,000 shares $4.10 million +1.6%N/A5.6 $3.18 7/15/20241,270,000 shares $3.62 million +32.6%N/A5.6 $2.85 6/30/2024957,600 shares $2.85 million -0.4%N/A4.4 $2.98 6/15/2024961,000 shares $2.55 million +13.1%N/A4.8 $2.65 5/31/2024849,600 shares $2.18 million -13.9%N/A4 $2.57 5/15/2024986,400 shares $2.73 million -6.1%N/A4.2 $2.77 4/30/20241,050,000 shares $3.08 million +16.9%N/A3.6 $2.93 4/15/2024898,400 shares $2.52 million -13.6%N/A3 $2.81 3/31/20241,040,000 shares $3.59 million -2.8%N/A3.5 $3.45 3/15/20241,070,000 shares $3.58 million -13.7%N/A3.8 $3.35 2/29/20241,240,000 shares $3.62 million +4.2%N/A4.2 $2.92 2/15/20241,190,000 shares $2.83 million -13.8%N/A2.7 $2.38 1/31/20241,380,000 shares $1.96 million +11.3%N/A3.6 $1.42 1/15/20241,240,000 shares $1.76 million +6.0%N/A3.2 $1.42 12/31/20231,170,000 shares $1.57 million +15.8%N/A3.1 $1.34 12/15/20231,010,000 shares $1.29 million -7.3%N/A2.8 $1.28 11/30/20231,090,000 shares $1.23 million -4.4%N/A3.4 $1.13 11/15/20231,140,000 shares $1.57 million -1.7%N/A6.4 $1.38 10/31/20231,160,000 shares $2.06 million -4.9%N/A14 $1.78 10/15/20231,220,000 shares $2.48 million -3.2%N/A18.8 $2.03 9/30/20231,260,000 shares $2.75 million -4.6%N/A17.5 $2.18 9/15/20231,320,000 shares $3.10 million +0.8%N/A14.1 $2.35 8/31/20231,310,000 shares $2.90 million -3.7%N/A6.5 $2.21 8/15/20231,360,000 shares $3.29 million +3.0%N/A4.1 $2.42 7/31/20231,320,000 shares $3.14 million +1.5%N/A3.6 $2.38 7/15/20231,300,000 shares $2.81 million -2.3%N/A3.3 $2.16 6/30/20231,330,000 shares $3.18 million +482.8%N/A3.5 $2.39 6/15/2023228,200 shares $588,756.00 -5.9%N/A0.6 $2.58 5/31/2023242,600 shares $524,016.00 -2.1%N/A1 $2.16 5/15/2023247,900 shares $654,456.00 -11.6%N/A1.5 $2.64 4/30/2023280,300 shares $964,232.00 +39.2%N/A3.4 $3.44 4/15/2023201,300 shares $380,457.00 +15.4%N/A3.2 $1.89Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. 3/31/2023174,400 shares $322,640.00 +51.9%N/A3.6 $1.85 3/15/2023114,800 shares $210,084.00 +73.2%N/A1.1 $1.83 2/28/202366,300 shares $158,457.00 -15.8%N/A0.6 $2.39 2/15/202378,700 shares $201,472.00 -11.6%N/A0.7 $2.56 1/31/202389,000 shares $207,370.00 -7.0%N/A0.8 $2.33 1/15/202395,700 shares $250,734.00 +0.8%N/A0.8 $2.62 12/30/202294,900 shares $183,157.00 -40.6%N/A0.7 $1.93 12/15/2022159,800 shares $356,354.00 -34.2%N/A0.8 $2.23 11/30/2022242,800 shares $456,464.00 -16.3%N/A1.2 $1.88 11/15/2022289,900 shares $637,780.00 -1.9%N/A1.2 $2.20 10/31/2022295,600 shares $585,288.00 -27.0%N/A1.1 $1.98 10/15/2022405,100 shares $725,129.00 +264.0%N/A1.3 $1.79 9/30/2022111,300 shares $171,402.00 +12.5%N/A0.3 $1.54 9/15/202298,900 shares $306,590.00 -9.9%N/A0.1 $3.10 8/31/2022109,700 shares $348,846.00 -2.3%0.6%0.1 $3.18 8/15/2022112,300 shares $424,494.00 -19.1%0.6%0.1 $3.78 7/31/2022138,800 shares $424,728.00 -29.9%1.1%0.1 $3.06 7/15/2022198,100 shares $691,369.00 +99.3%1.5%0.1 $3.49 6/30/202299,400 shares $279,314.00 +10.3%0.8%0.1 $2.81 6/15/202290,100 shares $199,121.00 -29.7%0.8%0.1 $2.21 5/31/2022128,100 shares $310,002.00 -48.5%1.1%0.2 $2.42 5/15/2022248,800 shares $549,848.00 -37.4%2.2%0.2 $2.21 4/30/2022397,500 shares $1.07 million -27.6%11.7%0.3 $2.70 4/15/2022548,900 shares $1.80 million +66.6%3.9%0.5 $3.28 3/31/2022329,400 shares $724,680.00 -60.4%2.3%0.3 $2.20 3/15/2022832,300 shares $1.22 million +40.9%N/A1.3 $1.46 2/28/2022590,800 shares $378,112.00 +286.9%4.5%1 $0.64 2/15/2022152,700 shares $79,251.30 +95.5%1.2%0.6 $0.52 1/31/202278,100 shares $49,804.37 +4.3%0.8%0.3 $0.64 1/15/202274,900 shares $53,830.63 -34.9%0.8%0.3 $0.72 12/31/2021115,100 shares $90,031.22 +16.6%1.2%0.2 $0.78 12/15/202198,700 shares $70,767.90 +16.7%1.0%0.2 $0.72 11/30/202184,600 shares $84,143.16 -42.2%1.2%0.2 $0.99 11/15/2021146,400 shares $161,040.00 -8.3%2.1%0.3 $1.10 10/29/2021159,700 shares $187,647.50 +14.3%2.8%0.4 $1.18 10/15/2021139,700 shares $180,213.00 +25.9%2.4%0.4 $1.29 9/30/2021111,000 shares $155,400.00 +26.1%1.5%0.4 $1.40 9/15/202188,000 shares $123,200.00 +43.1%1.2%1.5 $1.40 8/31/202161,500 shares $102,090.00 -23.8%0.8%0.8 $1.66 8/13/202180,700 shares $162,610.50 +11.3%1.1%1.2 $2.02 7/30/202172,500 shares $137,750.00 -28.0%1.1%1.1 $1.90 7/15/2021100,700 shares $196,365.00 +16.7%1.6%1.4 $1.95 6/30/202186,300 shares $194,175.00 -1.9%1.3%1.3 $2.25 6/15/202188,000 shares $196,240.00 -6.1%1.5%1.5 $2.23 5/28/202193,700 shares $199,581.00 +11.7%1.6%2.5 $2.13 5/14/202183,900 shares $168,639.00 +36.0%1.4%1.8 $2.01 4/30/202161,700 shares $144,995.00 -30.6%1.0%1 $2.35 4/15/202188,900 shares $221,805.50 +31.7%1.5%1 $2.50 3/31/202167,500 shares $193,050.00 -46.5%1.4%0.7 $2.86 3/15/2021126,200 shares $340,740.00 +132.4%2.9%1.1 $2.70No one’s talking about these Trump trades (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today 2/26/202154,300 shares $155,298.00 -16.3%1.2%0.5 $2.86 2/12/202164,900 shares $205,733.00 +2.0%1.5%0.6 $3.17 1/29/202163,600 shares $192,708.00 +35.6%1.5%0.7 $3.03 1/15/202146,900 shares $140,700.00 +4.9%1.1%0.7 $3.00 12/31/202044,700 shares $113,538.00 -0.9%1.0%1 $2.54 12/15/202045,100 shares $132,143.00 +14.5%1.1%1.3 $2.93 11/30/202039,400 shares $121,549.00 -12.4%0.9%1.7 $3.09 11/15/202045,000 shares $151,200.00 -5.9%1.6%1.6 $3.36 10/30/202047,800 shares $152,004.00 +13.8%1.7%1.1 $3.18 10/15/202042,000 shares $153,300.00 -40.8%1.5%0.5 $3.65 9/30/202070,900 shares $285,727.00 -9.6%2.5%0.8 $4.03 9/15/202078,400 shares $301,840.00 +185.1%2.7%0.8 $3.85 8/31/202027,500 shares $110,825.00 -67.1%1.0%0.3 $4.03 8/14/202083,700 shares $490,482.00 +65.7%3.3%0.6 $5.86 7/31/202050,500 shares $250,985.00 +18.5%1.9%0.4 $4.97 7/15/202042,600 shares $218,964.00 -29.9%1.6%0.5 $5.14 6/30/202060,800 shares $417,696.00 +1.8%2.4%0.7 $6.87 6/15/202059,700 shares $271,038.00 +7,362.5%2.3%0.5 $4.54 5/29/2020800 shares $2,216.00 -97.1%0.0%0 $2.77 5/15/202027,800 shares $77,840.00 +1.5%1.1%0.4 $2.80 4/30/202027,400 shares $78,364.00 +1,342.1%1.1%0.4 $2.86 4/15/20201,900 shares $5,424.50 -77.9%0.1%0 $2.86 3/31/20208,600 shares $24,768.00 +126.3%0.3%0.1 $2.88 3/13/20203,800 shares $10,260.00 +18.8%0.2%1.8 $2.70 2/28/20203,200 shares $7,552.00 -13.5%0.1%0.4 $2.36 2/14/20203,700 shares $14,430.00 -48.6%0.1%0.4 $3.90 1/31/20207,200 shares $41,760.00 -72.4%0.3%0.7 $5.80 1/15/202026,100 shares $136,242.00 -30.4%1.0%1.9 $5.22 12/31/201937,500 shares $194,250.00 +72.8%1.5%2.7 $5.18 TRVI Short Interest - Frequently Asked Questions What is Trevi Therapeutics' current short interest? Short interest is the volume of Trevi Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 1,410,000 shares of TRVI short. Learn More on Trevi Therapeutics' current short interest. What is a good short interest ratio for Trevi Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TRVI shares currently have a short interest ratio of 3.0. Learn More on Trevi Therapeutics's short interest ratio. Is Trevi Therapeutics' short interest increasing or decreasing? Trevi Therapeutics saw a drop in short interest in the month of November. As of November 30th, there was short interest totaling 1,410,000 shares, a drop of 19.4% from the previous total of 1,750,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Trevi Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Trevi Therapeutics: Arvinas, Inc. (13.13%), Day One Biopharmaceuticals, Inc. (28.49%), Ardelyx, Inc. (10.27%), Spyre Therapeutics, Inc. (18.20%), Calliditas Therapeutics AB (publ) (0.01%), ARS Pharmaceuticals, Inc. (26.75%), ANI Pharmaceuticals, Inc. (8.75%), Syndax Pharmaceuticals, Inc. (16.87%), Rocket Pharmaceuticals, Inc. (11.40%), Bicycle Therapeutics plc (4.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Trevi Therapeutics stock? Short selling TRVI is an investing strategy that aims to generate trading profit from Trevi Therapeutics as its price is falling. TRVI shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Trevi Therapeutics? A short squeeze for Trevi Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TRVI, which in turn drives the price of the stock up even further. How often is Trevi Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRVI, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies ARVN Short Interest Data DAWN Short Interest Data ARDX Short Interest Data SYRE Short Interest Data CALT Short Interest Data SPRY Short Interest Data ANIP Short Interest Data SNDX Short Interest Data RCKT Short Interest Data BCYC Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRVI) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
